Past Virtual Events

Share
Tumor board moderated by Dr. Dennis Chi, MSK and Dr. Rema P, RCC, Thiruvananthapuram
Multidisciplinary Tumor Board Mucinous Ovarian Neoplasms
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. Doctors from MSK in New York partnered with doctors from RCC, Thiruvananthapuram to present two mucinous ovarian neoplasms cases as part of an ongoing multidisciplinary tumor board series.
Tumor board moderated by Dr. Jasmeet C. Singh, MSK, New York and Dr. Andrew D. Seidman, MSK, New York of MSK and Dr. Atul Batra of AIIMS, India.
Unraveling the Challenges: Comprehensive Approach to Management of Oligoprogression in Breast Cancer
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) and Dr. Atul Batra (AIIMS, India) moderate a discussion with their fellow world-renowned colleagues about the management of oligoprogression in breast cancer.
Tumor board moderated by Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai and Dr. Mrinal Gounder of Memorial Sloan Kettering Cancer Center (MSK)
International Precision Oncology Tumor Board - Targeting the MEK Pathway
Join leading global experts to discover best practices on interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient.
Tumor board directed by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital, Mumbai.
International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
The second in an ongoing series led by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai, this tumor board focused on the BRAF pathway.
Tumor board moderators Dr. Jennifer Mueller of MSK and Dr. Thomas Samuel Ram of CMC Vellore
Multidisciplinary Tumor Board on Advanced/Recurrent Endometrial Cancer - MSK & CMC Vellore
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. To share expertise, advance research, and improve patient outcomes, Memorial Sloan Kettering Cancer Center (MSK) in New York is excited to present an educational series between MSK and the leading institutions of India. For this particular event, we are honored to partner with CMC Vellore in India.
Tumor board moderated by Dr. Snehal Patel of MSK and Dr. Anil D'Cruz of Apollo Hospital in Delhi.
Surgical Margins in Management of Oral Cancer - MSK & Apollo
Partnering with Apollo Hospital in Mumbai, India the multidisciplinary tumor board on May 19 included presentations on margin assessment, along with case studies on management of early oral cancer as well as locally advanced oral cancer.
VIDEO | 36:57
Presentation cover of ovarian cancer tumor board
March 25, 2022 - Multidisciplinary Tumor Board On Ovarian Cancer
We were excited to present an educational series between MSK and the Association of Gynaecologic Oncologists of India (AGOI). We were honored to co-host with Tata Medical Center in Kolkata and discussed treatment management of two serious ovarian cancer cases: platinum-sensitive recurrent ovarian cancer and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.
VIDEO | 1:29:50
Presentation cover on oral cancer overview
February 25, 2022 - Multidisciplinary Tumor Board On Oral Cancer: MSK and Tata Memorial
For this head and neck event, we co-hosted with the faculty of Tata Memorial Hospital, Mumbai. We discussed treatment management of complex oral cancer: early oral cancer with submucous fibrosis and locally advanced oral cancer with mandibular invasion. This was followed by a short lecture on state-of-the-art techniques in mandible reconstruction.
VIDEO | 1:33:39
Presentation cover of endometrial cancer tumor board
January 28, 2022 - Multidisciplinary Tumor Board on Endometrial Cancer: MSK and Manipal
In our inaugural event in the MSK-Association of Gynaecologic Oncologists of India (AGOI) joint tumor board series, we were honored to co-host with Manipal Comprehensive Cancer Center in Bengaluru. We discussed treatment management of two endometrial cancer cases: one localized early-stage and the other advanced recurrent. A short lecture followed on recent progress in advanced (metastatic) endometrial cancer.